A research programme by the Access to Medicine Foundation
  • In the media
  • Access to Medicine Index—what about sustainab...
Media - published on 21 Jan 2017

Access to Medicine Index—what about sustainability?

David L Heymann comments about the Access to Medicine Index in the Lancet. 

A summary of the article – A pharmaceutical company representative described the Access to Medicine Index 2016 as “a force for good, and not yet another stick with which to beat industry”.1 The Access to Medicine Index 2016,1which will be presented at a public meeting later this month at the time of the WHO Executive Board meeting in Geneva, ranks the top 20 research-based pharmaceutical companies on their efforts to improve access to medicine in low-income and middle-income countries (LMICs). And those companies with high ranking tout their success to their stockholders and the media.

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.